Latest Cash Flow News

The Calmer Co has reported a robust 26% increase in quarterly sales, driven by strong growth in Australia and the US, alongside a significant 39% reduction in cash used in operations, signaling clear progress toward profitability.

The Calmer Co. International Limited has delivered its strongest quarter yet, with revenue surging 26% to $2.4 million and operating cash outflows dropping to a historic low. Strategic growth across retail, e-commerce, and B2B channels underpins its confident path to breakeven.

Gale Pacific reports stabilising trading conditions in Q1 FY26 with a strategic U.S. operating model overhaul delivering significant cost savings, despite a slight dip in overall sales.

Microba Life Sciences reports a 145% jump in core microbiome test volumes and is on track to achieve regional break-even by FY26, supported by strategic cost cuts and a $14.5 million capital raise.

Winsome Resources has completed a focused drilling campaign at its Adina Lithium Project and revealed new high-grade cesium-lithium mineralised zones at Sirmac-Clapier, while strengthening its stake in Power Metals Corp.

xReality Group Limited delivered a record-breaking first quarter in FY26, driven by a landmark $5.7 million contract with the Texas Department of Public Safety and a rapidly growing US customer base.

AdAlta Limited has made significant progress in its 'East to West' cellular immunotherapy strategy, advancing licensing negotiations for its first CAR-T product and raising $1.6 million through placements to bolster its financial position.

Sunshine Metals Limited reported a solid cash position of AUD 5.1 million at the end of Q3 2025, supported by a strong financing inflow that offsets ongoing exploration expenditures.

Global Health Limited has accelerated its MasterCare+ SaaS platform rollout, integrating AI to streamline operations and reduce staff by 10%, while reporting a 25% EBIT improvement despite a delayed R&D refund impacting cash flow.

Sunshine Metals reports significant progress in North Queensland with standout gold intersections at Sybil and a $5 million placement led by Lion Selection. Board reshuffle aligns leadership with growth strategy.

Algorae Pharmaceuticals has broadened its commercial footprint in Australia and New Zealand through key licensing agreements, while advancing its AI-driven drug discovery platform and strengthening leadership.

Tarrina Resources is set to acquire promising exploration assets in NSW and SA, backed by a $5 million capital raise. The move aims to reposition the company within the mining sector and secure its ASX listing.